Join PHI’s CA Bridge for “Sustaining Emergency Department Buprenorphine Services” (Webinar)
Sustaining ED Buprenorphine Services
Panel Discussion with California Leaders
Tuesday April 26, 2022
3:00pm – 4:00 pm ET / 12:00pm – 1:00pm PT
Starting people on opioid use disorder (OUD) treatment in the ER can help reduce the risk of overdose death and connect people to treatment. While this approach has been adopted in many hospital settings across states, Medicaid payment and sustainability remain challenging for state leaders.
Join the National Academy for State Health Policy for a panel discussion on state opportunities to address policy and payment solutions for sustainability, featuring:
- Arianna Sampson Campbell, PA-C, Director/Co-Principal Investigator of PHI’s CA Bridge;
- Kelly Pfeifer, MD, Deputy Director of Behavioral Health for the California Department of Health Care Services;
- Moderated by Karen A. Scott, President of the Foundation for Opioid Response Efforts
CA Bridge: Transforming Addiction Treatment
PHI's CA Bridge saves lives by making it possible for people who use drugs to get treatment at any hospital—whenever and wherever they need it.
The CA Bridge model advances evidence-based medications for addiction treatment (MAT), particularly buprenorphine, which reduces relapse among people suffering from opioid use disorder. Lowering barriers to treatment, the model also helps to eliminate unnecessary tests and provide patients in withdrawal with immediate relief from withdrawal symptoms. Once patients are stabilized, they are better equipped to engage in a conversation about long-term treatment with a substance use navigator—a peer from the community, often with lived experience. Using a harm reduction perspective that emphasizes rapid, patient-centered care, the CA Bridge model is proven to work effectively in any hospital setting.